Kvsh Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 72.64%
- Profit Growth 170.41%
- Ebitda 181.32%
- Net Worth 69.31%
- Total Assets -6.85%
About Kvsh Pharma
Kvsh Pharma Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 April 2017 (Seven years and nine months 19 days old ). Its registered office is in Tiruvannamalai, Tamil Nadu, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abboy Karunanithi, Sathish Karunanithi, Senthil Karunanithi, and One other member serve as directors at the Company.
Company Details
-
Location
Tiruvannamalai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2017PTC116196
-
Company No.
116196
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Apr 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Kvsh Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abboy Karunanithi
|
Director | 21-Apr-2017 | Current |
|
Sathish Karunanithi
|
Director | 21-Apr-2017 | Current |
|
Senthil Karunanithi
|
Director | 21-Apr-2017 | Current |
|
Vasantha Karunanidhi
|
Director | 21-Apr-2017 | Current |
Financial Performance of Kvsh Pharma.
Kvsh Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 72.64% increase. The company also saw a substantial improvement in profitability, with a 170.41% increase in profit. The company's net worth Soared by an impressive increase of 69.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kvsh Pharma?
Unlock access to Kvsh Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Regbex Life Sciences Private LimitedAbboy Karunanithi is a mutual person
-
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kvsh Pharma?
Unlock and access historical data on people associated with Kvsh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kvsh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kvsh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.